US Patent Issued to iCell Gene Therapeutics on Sept. 15 for "Chimeric antigen receptors (CARs) targeting hematologic malignancies, compositions and methods of use thereof" (New York Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,471, issued on Sept. 15, was assigned to iCell Gene Therapeutics Inc. (Stony Brook, N.Y.).

"Chimeric antigen receptors (CARs) targeting hematologic malignancies, compositions and methods of use thereof" was invented by Yupo Ma (Stony Brook, N.Y.), Kevin Pinz (Stony Brook, N.Y.), Xun Jiang (Stony Brook, N.Y.), Masayuki Wada (Stony Brook, N.Y.) and Kevin Chen (Stony Brook, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides chimeric anti-gen receptor polypeptides having antigen recognition domains for CD2, CD3, CD4, CD5, CD7, CD8, and CD52 antigens, and polynucleotides encoding for the same. The present disclosure also...